Cargando…
Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
Leishmaniasis is a vector-borne neglected tropical disease caused by protozoan parasites of the genus Leishmania for which there is a paucity of effective viable non-toxic drugs. There are 1·3 million new cases each year causing considerable socio-economic hardship, best measured in 2·4 million disa...
Autores principales: | CHARLTON, REBECCA L., ROSSI-BERGMANN, BARTIRA, DENNY, PAUL W., STEEL, PATRICK G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964475/ https://www.ncbi.nlm.nih.gov/pubmed/28805165 http://dx.doi.org/10.1017/S0031182017000993 |
Ejemplares similares
-
Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development
por: Seifert, Karin
Publicado: (2011) -
Microbial food: microorganisms repurposed for our food
por: Choi, Kyeong Rok, et al.
Publicado: (2021) -
Intranasal Vaccination with Leishmanial Antigens Protects Golden Hamsters (Mesocricetus auratus) Against Leishmania (Viannia) braziliensis Infection
por: da Silva-Couto, Luzinei, et al.
Publicado: (2015) -
Transcriptional profiling of microglia; current state of the art and future perspectives
por: Gerrits, Emma, et al.
Publicado: (2019) -
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment
por: Awisat, Abid, et al.
Publicado: (2023)